4965-34-8

Basic information

• Product Name: 7-BROMO-2-METHYLQUINOLINE
• Synonyms: 7-BROMO-2-METHYLQUINOLINE;2-Methyl-7-broMoquinoline
• CAS NO: 4965-34-8
• Molecular Formula: C₁₀H₈BrN
• Molecular Weight: 222.0812
• EINECS: -0
• Mol File: 4965-34-8.mol
• Article Data: 1

Chemical Properties

• Melting Point: 77-79 °C
• Boiling Point: 299.68 °C at 760 mmHg
• Flash Point: 135.042 °C
• Appearance: /
• Density: 1.488 g/cm³
• Vapor Pressure: 0.002mmHg at 25°C
• Refractive Index: 1.654
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 4.25±0.50(Predicted)
• CAS DataBase Reference: 7-BROMO-2-METHYLQUINOLINE(CAS DataBase Reference)
• NIST Chemistry Reference: 7-BROMO-2-METHYLQUINOLINE(4965-34-8)
• EPA Substance Registry System: 7-BROMO-2-METHYLQUINOLINE(4965-34-8)

Safety Data

• Statements: 41
• Safety Statements: 26-39
• Hazardous Substances Data: 4965-34-8(Hazardous Substances Data)

Usage

Chemical Properties

yellow powder

InChI:InChI=1/C10H8BrN/c1-7-2-3-8-4-5-9(11)6-10(8)12-7/h2-6H,1H3

Upstream product

• 591-19-5 m-Bromoaniline 
• 123-63-7 paracetaldehyde 

Downstream Products

• 108166-09-2 7-bromo-2-<2-(3-acetoxyphenyl)-(E)-ethenyl>quinoline 
• 19490-87-0 7-methoxy-2-methylquinoline 
• 1352204-62-6 tert-butyl 4-(2-((3-phenylpropanoyloxy)methyl)quinolin-7-yl)piperazine-1-carboxylate 
• 165112-03-8 7-hydroxy-2-methylquinoline 
• 64334-96-9 2-methylquinolin-7-amine 
• 904369-20-6 7-bromoquinoline-2-carbaldehyde 
• 108165-87-3 (D,L) 2-(3-(2-(7-bromoquinolin-2-yl)ethynyl)phenoxy)propanoic acid sodium salt 
• 108177-35-1 methyl D,L-2-<3-<2-(7-bromo-2-quinolinyl)ethynyl>phenoxy>propanoate 
• 143816-70-0 3-<2-(7-bromo-2-quinolinyl)ethynyl>phenyl acetate 
• 108193-13-1 3-<2-(7-bromo-2-quinolinyl)ethynyl>phenol 
• 168083-22-5 3-(7-bromo-2-quinolinylmethoxy)aniline 

Relevant articles and documents

X-RAY AND GAMMA-PHOTON ACTIVABLE ORGANIC COMPOUNDS, THEIR PREPARATION AND THEIR USES

The present invention relates to a X-ray and gamma-photon activable compound responding to the following formula (I). The present invention also relates to methods of synthesizing a compound according to the invention, and to an aqueous or physiological solution comprising at least one compound of the invention. The present invention also concerns a method of liberating a biologically active compound, said method involving the step of irradiating at least one compound, or at least one aqueous or physiological solution according to the invention. Finally, the present invention relates to a pharmaceutical composition comprising at least one compound, or at least one aqueous or physiological solution according to the invention.